Your region is set to . If this is incorrect, please change your region.

Konrad A. Sechley, PhD
Principal, Patent Agent

Primary Office: Vancouver

Konrad A. Sechley, PhD

Konrad Sechley is a leading patent agent in the life sciences sector with over 20 years of experience in patent prosecution. Working out of Gowling WLG's Vancouver office, Konrad is known for his proactive approach and resourcefulness in pursuing success for his clients.

His practice focuses on patent protection in the biotechnological, agricultural, pharmaceutical, chemical, cleantech, biofuel and bioenergy sectors in Canada, the U.S. and abroad. He works with a full range of clients, including government, university and hospital research labs, and startup and mid-sized biotech, cleantech, pharmaceutical and multinational corporations. Konrad is a registered patent agent in Canada and the United States, and a qualified Canadian patent examiner.

Top-ranked by major legal directories such as LMG Life Sciences, IAM Patent 1000 and Who's Who Legal Patents, he speaks and publishes regularly on current patent issues in the life sciences. 

Prior to joining Gowling WLG, Konrad worked as a post-doctoral research scientist in several university, government and industrial research labs in the fields of biochemistry and molecular biology.

Konrad is the former leader of the firm's Life Sciences Group, and is a former national leader of its Patent Prosecution Group. He also contributes to the advancement of the profession by being an active member of the Biotechnology Committee with the Intellectual Property Institute of Canada (IPIC) and the Biotechnology and Chemical Practice Committees with the American Intellectual Property Institute (AIPLA). He is also involved in the training of patent agents and is currently chair of IPIC's Patent Agent Training Tutorials. Konrad is also a past IPIC council member.


"Konrad ... provides excellent guidance in terms of strategic positioning of new concepts and ideas, continuously anticipates legal issues and opportunities ..."
LMG Life Sciences 2014

December2015

Who’s Who Legal: Canada 2015

October2015

LMG Life Sciences 2015

July2015

IAM Patent 1000, 2015

Featured insights & resources

Memberships

Career & Recognition

2016

2016

2015

December 2015

Who’s Who Legal: Canada 2015

2015

October 2015

LMG Life Sciences 2015

2015

July 2015

IAM Patent 1000, 2015

2015

July 2015

Who’s Who Legal: Patents 2015

2014

November 2014

LMG Life Sciences 2014

2014

September 2014

Who’s Who Legal: The International Who’s Who of Business Lawyers 2014

2014

July 2014

Canadian Legal Lexpert Directory 2014

2014

July 2014

IAM Patent 1000, 2014

2013

November 2013

Who's Who Legal: Canada 2013

2013

September 2013

Who’s Who Legal – The International Who’s Who of Patent Lawyers 2013

2013

August 2013

LMG Life Sciences 2013

2013

July 2013

Canadian Legal Lexpert Directory 2013

2013

June 2013

IAM Patent 1000, 2013

2013

2013

Council member, IPIC

2013 - 2015

2012

July 2012

IAM Patent 1000, 2012

2012

June 2012

PLC Which Lawyer? 2012

2011

2011

Chair, Life Sciences Group

2010

February 2010

Canadian Legal Lexpert Directory, 2010

2010

2010

Chair, Patent Agent Training Committee

2010 - 2014

2009

2009

Chair, Patent Agent Tutorials

2004

2004

Head, Patent Prosecution Practice Group

2004 - 2010

2000

2000

Gowling Lafleur Henderson LLP, Partner

1995

1995

Registered Patent Agent, Canada

1993

1993

Candian Patent Examiner

1993 - 1996

1986

1986

Carleton University, PhD

1986

1986

Research Scientist

1986 - 1993

Named leading practitioner by Canadian Legal Lexpert Directory, 2008 - 2009

York University, B.Sc.

Konrad Sechley
Profile highlights

#
Konrad Sechley

Konrad Sechley is a leading patent agent in the life sciences sector with over 20 years of exp...

Memberships

Konrad Sechley
Profile highlights

#
Konrad Sechley

Konrad Sechley is a leading patent agent in the life sciences sector with over 20 years of exp...

Insights & Resources

EXTERNAL PUBLICATIONS &
PAST SPEAKING ENGAGEMENTS

Konrad has published numerous articles and speaks regularly on IP protection in biotechnology.

  • Chapter 2, “Patent Law," in Life Sciences Law in Canada, 2015, co-authored with J. Wilkie; A. Blanchard and J. Steinberg, eds, Thompson Pub.
  • “Developing issues in obtaining patent protection for plant based vaccines and natural products” presented at the Plant Based Vaccines, Antibodies, Biologics Conference, June 8-10, 2015 Lausanne, Switzerland.
  • “Patent protection for genes and natural products” presented at Hot Topics in Life Sciences workshop May 6th, 2015, Vancouver, BC.
  • Webinar on patent drafting, presented at the Intellectual Property Institute of Canada, March 30, 2015
  • “Promise of the patent,” presented at the CILS Conference on International Intellectual Property Law, co-chaired with David Aylen, Austria, Jan. 25-30, 2015
  • “Update on what is patentable in life sciences,” presented at the BIO PacRim Summit, San Diego, Dec. 7-9, 2014
  • Patent issues in personalized medicine in Canada and Europe,” co-authored with Emma Macfarlane, International Journal of Law and Medicine 2014, pp. 245-263, 2014
  • Book chapter in: “International post-grant and related proceedings, Section VIII: Canada,” co-authored with John Norman and Connie Too, in “Patent Office Litigation,” Thomson Reuters
  • "Personalized medicine: patent issues in Canada and Europe," co-authored with Emma Macfarlane, Life Sciences and Law 2014-2015
  • Chair of IPIC Patent Agent Tutorials, tutor for patent drafting module, Gatineau, Que., February 24-25, 2014
  • "Patent update in the life science sector," presented at the Center for International Legal Studies, Austria, Jan. 31, 2014
  • “What is patentable in the biotech sector?”, presented at the BIO PacRim Summit, San Diego, Dec. 8-11, 2013
  • “Protecting personalized medicine: patents, enforcement and data protection,” co-presented with C. Van Barr, Canadian Consulate Japan, Tokyo, Dec. 4, 2013, and Osaka, Tokyo, Dec. 6, 2013
  • "Too much? Too little? Just right? Increased scrutiny of the description and the goldilocks syndrome," presented at the Intellectual Property Institute of Canada AGM, Sept. 26, 2013
  • “Current issues on patent protection — a comparative overview of issues pertaining to plant related protection considering the U.S., Europe and Canada,” presented at teh Plant Based Vaccines, Antibodies, Biologics Conference, Verona, Italy, June 5-7, 2013
  • "Not all first to file systems are the same,” co-authored with Clare Salisbury, Life Sciences and Law 2013-2014
  • Chair of IPIC Patent Agent Tutorials and tutor for patent drafting module, Gatineau, Que., March 4-5, 2013
  • CILS Conference on International Intellectual Property Law, co-chaired with David Aylen, Austria, Jan.27-Feb. 1, 2013; presented paper: “Not all first to file systems are the same”
  • “Methods of medical treatment claims in Canada, Europe and the U.S.,” co-presented webinar with Scott Foster, Nov. 29, 2012
  • "Intellectual property — an international view," University of British Columbia, March 14, 2012
  • Chair of IPIC Patent Agent Tutorials and tutor for Patent Drafting module, Gatineau, Que., Feb. 27-28, 2012
  • "Developments in Canadian life science patent law," Conference on International Law, Center for International Legal Studies, Denver Colo., Feb. 13-17, 2012
  • "IP strategies for life science companies," co-presented with Sean Alexander, Gowlings Life Science webinar series, Nov. 28, 2011
  • "Identifying and protecting intellectual property/pursuing partnerships with the private sector," Edmonton, Alta., Innovates Health Solutions, Oct. 13, 2011  
  • "Patent drafting and prior art," Toronto, tutor in FICPI patent claim drafting work shop, Oct. 1-2, 2011  
  • "America invents act," Vancouver, University of British Columbia, University Industry Liaison Office, Sept.29, 2011
  • "Global markets and foreign IP laws — IP issues for life sciences companies," co-presented with Sean Alexander at the Vancouver Licensing Executive Society, May 25, 2011
  • "Patent protection in biofuels and bioenergy," in Life Sciences & Law, 2011/12
  • "Methods of medical treatment and dosage claims," co-authored with Gloria Hsi and Alaka Chatterjee, Life Sciences & Law, 2011/12
  • "Intellectual property," Student Biotechnology Network, Venture Ready Program, Vancouver, May 24, 2011
  • "Getting the IP strategy that is right for you," co-authored with Jane Clark, John Norman, Mary Thomson and Jennifer Wilkie, Insights Magazine, BIOTECanada, Spring 2011
  • "Patent protection in bioenergy and biofuels, a global view," BIO - World Congress on Industrial Biotechnology & Bioprocessing, Toronto, May 8-11, 2011
  • "Patent drafting," Gatineau, Que., Intellectual Property Institute of Canada Patent Agent Training Tutorials, Feb. 28 - March 1, 2011; Chair of 2011 Patent Agent Tutorials
  • "Emerging challenges for obtaining patent protection in the life sciences," Salzburg, Austria, Centre for International Legal Studies, Feb. 2, 2011
  • "IP: What's in it for you," Canadian Intellectual Property Office Bank of Speakers Workshop, Bow Valley College, Calgary, Jan.26, 2011

Client Work

Konrad Sechley
Profile highlights

#
Konrad Sechley

Konrad Sechley is a leading patent agent in the life sciences sector with over 20 years of exp...

Find similar people

Intellectual Property

Intellectual Property

Patents

Patents

Food & Beverage

Food & Beverage

Life Sciences

Life Sciences

Tech

Tech